Table 1.
Number of tested pre/-post-mortem sample pairs* of either serum or plasma in each examined serological assay
| Material | Tested pre-/post-mortem sample pairs in each assay, n | |||||||
|---|---|---|---|---|---|---|---|---|
| HBsAg | anti-HBc | anti-HCV | anti-HIV | anti-T. pallidum | anti-HTLV | anti-HBs | HBs-Ag-NT | |
| Serum | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 9 |
| Plasma | 6 | 11 | 11 | 11 | 11 | 12 | 12 | 6 |
| Total | 25 | 30 | 30 | 30 | 30 | 31 | 31 | 15 |
*
Because of limited sample volume, not all spiking tests could be performed for all samples (in this case, only the unspiked sample was analysed and test value quotient of pre- and post-mortem samples was determined).